AMILORIDE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for amiloride hydrochloride and what is the scope of patent protection?
Amiloride hydrochloride
is the generic ingredient in five branded drugs marketed by Chartwell Rx, Endo Operations, Sigmapharm Labs Llc, Padagis Us, Barr, Rising, Teva, Watson Labs, Par Pharm, and Merck, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for amiloride hydrochloride. Four suppliers are listed for this compound.
Summary for AMILORIDE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 10 |
NDAs: | 11 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 65 |
Patent Applications: | 1,892 |
What excipients (inactive ingredients) are in AMILORIDE HYDROCHLORIDE? | AMILORIDE HYDROCHLORIDE excipients list |
DailyMed Link: | AMILORIDE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for AMILORIDE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | Phase 1 |
Venkata Yellepeddi | Early Phase 1 |
University of Utah | Early Phase 1 |
Pharmacology for AMILORIDE HYDROCHLORIDE
Drug Class | Potassium-sparing Diuretic |
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Medical Subject Heading (MeSH) Categories for AMILORIDE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for AMILORIDE HYDROCHLORIDE
US Patents and Regulatory Information for AMILORIDE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | MODURETIC 5-50 | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 018201-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Padagis Us | MIDAMOR | amiloride hydrochloride | TABLET;ORAL | 018200-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Watson Labs | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 073334-001 | Jul 19, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 073357-001 | Nov 27, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.